Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy

Küçük Resim Yok

Tarih

2016

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Institute of Experimental Endocrinology

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Objective. Roux-en-Y gastric bypass (RYGB) is an independent risk factor for moderate hypocalcaemia and may lead to the development of resistant hypocalcaemia following thyroid surgery. Subject and Results. A 35-year old female patient was referred to our hospital by her family physician for treatment of resistant hypocalcaemia. The patient underwent RYGB three years ago and a total thyroidectomy for a benign thyroid nodule one year ago. Calcitriol, calcium carbonate, magnesium oxide, and ergocalciferol therapeutic dosages were incremented. Despite dosage increments, the desired calcium levels were not achieved. In the sixth month after admission to our hospital, pancrelipase was added to patient’s treatment scheme. On the following visit, a good calcium increase had been achieved. Conclusion. This report presents a case history of RYGB and resistant hypocalcaemia, which developed after thyroid surgery and positively responded to pancrelipase treatment. © 2016, Institute of Experimental Endocrinology. All rights reserved.

Açıklama

Anahtar Kelimeler

Bariatric surgery, Hypocalcaemia, Hypoparathyroidism, Thyroidectomy

Kaynak

Endocrine Regulations

WoS Q Değeri

Scopus Q Değeri

Q3

Cilt

50

Sayı

1

Künye